|
Drug Development Summit 2008 Speaking Faculty:
Alejandro Aruffo, Vice President, Global Development, Abbott Laboratories
Michael J. Butler, Chief Scientific Officer, Aptuit
Jan M. Lundberg, PhD, Executive Vice President,Global Discovery Research, AstraZeneca
David T. Lin, PhD, Sr. Consultant, Biologics Consulting Group
Brian Daniels, Sr. Vice President, Global Clinical Development, Bristol-Myers Squibb
Patty Spinner, Group Publisher, Pharmaceutical Media Group, Canon Communications
Jeff Alder, Head, Drug Discovery and Evaluation, Cubist Pharmaceuticals
Terri Cooper, PhD, National Leader, Life Sciences R&D Practice, Deloitte Conulting LLC
Troy Harmon, Vice President, Drug Development, Eurand
Seigo Izumo, Global Head of Cardiovascular Research, Novartis Institutes for BioMedical Research (NIBR), Novartis
Kapil Dhingra, MD, Vice President and Disease Biology Leader - Oncology, Roche
Daniel M. Perlman, Chief Executive Officer, Research Pharmaceutical Services RPS
Harris Koffer, President & COO, Research Pharmaceutical Services RPS
David L. Day, Director, Office of Technology Licensing and Sid Martin Biotechnology Development Incubator, University Florida
Robert R. Ruffolo Jr., PhD, President, Research & Development, Wyeth Pharmaceuticals, Sr. Vice President, Wyeth Corporation, Wyeth
|
|
